HAIFA, Israel, Nov. 16, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today reported that the company will present two key aspects of its clinical trials -- quality and ...
In spite of the huge potential impact of microbiome science, current measurement capabilities are insufficient, particularly for translating discoveries and correlations observed in the lab into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback